From Mankind to Alkem, top five pharma firms hit by the ban on FDCs
These drugs were found to be irrational and without therapeutic justification
 "drugs, generics, drug, pharma, pharmaceuticals, medicines, tablets, capsules, healthcare, IPR")
premium
Some major Western concerns about India's patent framework are the definitions of inventions and provisions for compulsory licensing
The health ministry last week banned 328 fixed dose combination drugs (FDCs) following recommendations of the drug technical advisory board. These drugs were found to be irrational and without therapeutic justification. Also, manufacture and sale of six other FDCs has been regulated. Fifteen FDCs have been exempted from the ban in accordance with the order of the SC.